Cargando…
Expression of 3q oncogene SEC62 in atypical fibroxanthoma-immunohistochemical analysis of 41 cases and correlation with clinical, viral and histopathologic features
Atypical fibroxanthoma (AFX) is a rare mesenchymal tumor with predominance in older male patients located mainly in chronically UV-exposed skin. Differentiation from clinically more aggressive pleomorphic dermal sarcoma (PDS) is still under debate and immunohistochemical markers are not available ye...
Autores principales: | Müller, Cornelia S.L., Kreie, Léa, Bochen, Florian, Pfuhl, Thorsten, Smola, Sigrun, Gräber, Stefan, Vogt, Thomas, Schick, Bernhard, Linxweiler, Maximilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341582/ https://www.ncbi.nlm.nih.gov/pubmed/30675236 http://dx.doi.org/10.3892/ol.2018.9767 |
Ejemplares similares
-
Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas
por: Bochen, Florian, et al.
Publicado: (2016) -
Expression of SEC62 Oncogene in Benign, Malignant and Borderline Melanocytic Tumors—Unmasking the Wolf in Sheep’s Clothing?
por: Müller, Cornelia S. L., et al.
Publicado: (2021) -
Let’s talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine
por: Linxweiler, Maximilian, et al.
Publicado: (2017) -
The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors
por: Zimmermann, Julia S. M., et al.
Publicado: (2022) -
Antagonizing Sec62 function in intracellular Ca(2+) homeostasis represents a novel therapeutic strategy for head and neck cancer
por: Körner, Sandrina, et al.
Publicado: (2022)